However, studies demonstrated that this drug increases the level of ROS in tumor cells, which stabilizes hypoxia-inducible-factor-1α (HIF-1α), a factor leading to tumor tolerance to chemotherapy. The gene discussed is HIF1A; the disease is neoplasm.